COVID-19 – Professional Resources & Guidance

NHS England COVID-19 Guidance – NHS England COVID-19 Specialty Guides  UK Government COVID-19 resources – NHS COVID-19 resources NICE COVID-19 resources – NHS SPS COVID-19 resources – RDTC HEE e-Learning for Health COVID-19 Courses Medicines for End of Life & Critical Care Alphabetical List – with thanks to SPS Several Professional, Academic & Representative Bodies have compiled collections of COVID-19 guidance Continue Reading »

Welcome to the Medicines Optimisation website

This website is maintained by North of England Commissioning Support Medicines Optimisation Team and contains medicines information, guidelines and resources to support safe, effective and good value medicines use in primary care in the NHS across the North East, North Cumbria, Humberside and parts of North & West Yorkshire.

COVID-19 Maintaining Immunisation Programmes – PHE Guidance

Public Health England – with support from the Royal College of General Practitioners and the Royal College of Paediatrics and Child Health – have published Clinical guidance for healthcare professionals on maintaining immunisation programmes during COVID-19. The guidance sets out the following key points for General Practice: The routine immunisation programme should be maintained. As well as protecting Continue Reading »

Supply Issues & Shortages – DHSC Updates reinstated via SPS

The DHSC has reinstated publication of monthly reports and information on current issues affecting supply of medicines in England via the NHS Specialist Pharmacy Service website: https://www.sps.nhs.uk/articles/department-of-health-and-pharmaceutical-market-strategy-group-pmsg-supply-updates/  The monthly Supply Issues Updates for Primary and Secondary Care and linked documents are also circulated through the PrescQIPP network and form the core of the Notts APC COVID-19 Supply Issues Continue Reading »

COVID-19 & ACE-inhibitors or ARBs

NICE has published COVID-19 rapid evidence summary: angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) in people with or at risk of COVID-19 – which includes the following conclusion: Despite biological plausibility for the role of ACEIs and ARBs in both increasing and decreasing the risk of COVID-19 and its complications, this evidence review has not found any Continue Reading »

COVID-19 & NSAIDs – NICE Advice

NICE has published a COVID-19 rapid evidence summary on Long-term use of non-steroidal anti-inflammatory drugs (NSAIDs) for people with or at risk of COVID-19 – which includes the following conclusion: No evidence was found to suggest that people taking NSAIDs for a long-term condition should be advised to stop treatment in the context of COVID‑19. Stopping or switching NSAID treatment Continue Reading »